Federal Funding Opportunities

Winship investigators have access to an extensive listing of cancer-related funding issued by the National Institutes of Health and other federal agencies. The listing updates automatically on a daily basis.

Use the column sorting, search filtering, and pagination tools to find and select federal funding opportunities below.

Cascade Link

Opportunity	Posted	Closing
DoD Breast Cancer, Breakthrough Award Levels 1 and 2 Agency: AMRAA	07/17/18	11/15/18
DoD Breast Cancer, Breakthrough Award Levels 3 and 4 Agency: AMRAA	07/17/18	12/10/18
Diet and Physical Activity Assessment Methodology (R01 Clinical Trial Not Allowed) Agency: NIH Institutions: NIDDKNCINIAAANIMHDNCCIH	07/17/18	09/07/21
Diet and Physical Activity Assessment Methodology (R21 Clinical Trial Not Allowed) Agency: NIH Institutions: NIDDKNCINIAAANIMHDNINR	07/17/18	09/07/21
Time-Sensitive Obesity Policy and Program Evaluation (R01 Clinical Trial Not Allowed) Agency: NIH Institutions: NIDDKNCINICHDODPOBSSR	07/12/18	09/10/21
Cervical Cancer Screening Agency: ZIM	07/12/18	08/11/18
DoD Peer Reviewed Cancer, Horizon Award Agency: AMRAA	07/12/18	09/26/18
Administrative Supplements to Promote Collaborative Activities in Basic Cancer Research (Admin Supp - Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	07/05/18	08/06/18
Electronic Nicotine Delivery Systems (ENDS): Population, Clinical and Applied Prevention Research (R01 - Clinical Trial Optional) Agency: NIH Institutions: ODPNCINIDCRNIDANIMHD	06/29/18	06/27/20
Electronic Nicotine Delivery Systems (ENDS): Basic Mechanisms of Health Effects (R01 - Clinical Trial Not Allowed) Agency: NIH Institutions: ODPNCINIDCRNIDANIEHS	06/29/18	06/27/20
Electronic Nicotine Delivery Systems (ENDS): Basic Mechanisms of Health Effects (R21 - Clinical Trial Not Allowed) Agency: NIH Institutions: ODPNCINIDCRNIDANIEHS	06/29/18	06/27/20
Electronic Nicotine Delivery Systems (ENDS): Population, Clinical and Applied Prevention Research (R21 - Clinical Trial Optional) Agency: NIH Institutions: ODPNCINIDCRNIDANIMHD	06/29/18	06/27/20
Administrative Supplements to Support Cancer Disparity Collaborative Research (Clinical Trial Optional) Agency: NIH Institutions: NCI	06/28/18	09/10/18
Oncology Co-Clinical Imaging Research Resources to Encourage Consensus on Quantitative Imaging Methods and Precision Medicine (U24 - Clinical Trial Optional) Agency: NIH Institutions: NCI	06/28/18	06/14/21
Collaborative Human Tissue Network (CHTN) (UM1 Clinical Trials Not Allowed) Agency: NIH Institutions: NCI	06/22/18	08/28/18
Administrative Supplements to Promote Diversity in Small Businesses-SBIR/STTR (Admin Supp Clinical Trial Not Allowed) Agency: NIH Institutions: NCINEINHGRINIANIAAANIAIDNIBIBNIDCRNIDANIGMSNINDSNINRNIMHDNCCIHNCATS	06/20/18	09/04/21
DoD Prostate Cancer, Health Disparity Research Award Agency: AMRAA	06/19/18	10/11/18
Prostate Cancer, Health Disparity Fellowship Award Agency: AMRAA	06/19/18	10/11/18
Partnership for Disaster Health Response Agency: ASPR	06/14/18	08/15/18
The Role of Epitranscriptomics in Development and Disease (R01 - Clinical Trial Not Allowed) Agency: NIH Institutions: NICHDNCINEI	06/14/18	06/03/21
NCI Community Oncology Research Program (NCORP) Community Sites (UG1 Clinical Trial Required) Agency: NIH Institutions: NCI	06/13/18	08/31/18
NCI Community Oncology Research Program (NCORP) Research Bases (UG1 Clinical Trial Required) Agency: NIH Institutions: NCI	06/13/18	08/31/18
NCI Community Oncology Research Program (NCORP) Minority/Underserved Community Sites (UG1 Clinical Trial Required) Agency: NIH Institutions: NCI	06/13/18	08/31/18
NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required) Agency: NIH Institutions: ODS	06/13/18	11/04/19
DoD Kidney Cancer, Concept Award Agency: AMRAA	06/08/18	08/08/18
Rare Diseases Clinical Research Consortia (RDCRC) for Rare Diseases Clinical Research Network (U54 Clinical Trials Optional) Agency: NIH Institutions: NCATSNCINHLBINIAIDNIAMSNICHDNIDCRNIDDKNINDS	06/08/18	10/09/18
DoD Kidney Cancer, Physician Research Award Agency: AMRAA	06/08/18	09/26/18
DoD Kideny Cancer, Technology Development Award Agency: AMRAA	06/08/18	09/26/18
DoD Kidney Cancer, Translational Research Partnership Award Agency: AMRAA	06/08/18	09/26/18
DoD Kideny Cancer, Idea Development Award Agency: AMRAA	06/08/18	09/26/18
Collaborative Activities to Promote Cancer Cachexia Research (Admin Supp - Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	06/07/18	07/30/18
Administrative Supplements for Research on Dietary Supplements (Admin. Supp.- Clinical Trial Not Allowed) Agency: NIH Institutions: ODSNCINEINHLBINIANIAAANIAIDNIAMSNIDCDNIDCRNIDDKNIEHSFICNCCIHORIP	06/05/18	04/15/20
Administrative Supplements for Validation Studies of Analytical Methods for Dietary Supplement Constituents (Admin Supp - Clinical Trial Not Allowed) Agency: NIH Institutions: ODSNCINIDDKNIEHSNCCIH	06/05/18	04/15/20
Radiation Protection of the Public as Practiced by the State and Local Radiation Programs Agency: NCEH	05/31/18	07/31/18
Cancer Prevention, Diagnosis, and Treatment Technologies for Low-Resource Settings (R41/R42 - Clinical Trial Optional) Agency: NIH Institutions: NCI	05/24/18	01/05/21
Cancer Prevention, Diagnosis, and Treatment Technologies for Low-Resource Settings (R43/R44 - Clinical Trial Optional) Agency: NIH Institutions: NCI	05/24/18	01/05/21
Prostate Cancer, Early Investigator Research Award Agency: AMRAA	05/21/18	09/06/18
DoD Prostate Cancer, Physician Research Award Agency: AMRAA	05/21/18	09/06/18
DoD Prostate Cancer, Idea Development Award Agency: AMRAA	05/21/18	09/27/18
DoD Prostate Cancer, Impact Award Agency: AMRAA	05/21/18	10/18/18
Precision Imaging of Oral Lesions (R01- Clinical Trial Not Allowed) Agency: NIH Institutions: NIDCRNIBIBNCI	05/16/18	09/07/21
Investigation of the Transmission of Kaposi Sarcoma-Associated Herpesvirus (KSHV) (R21 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	05/10/18	08/16/18
Investigation of the Transmission of Kaposi Sarcoma-associated Herpesvirus (KSHV)(R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	05/10/18	08/16/18
DoD Lung Cancer, Concept Award Agency: AMRAA	05/03/18	08/09/18
DoD Lung Cancer, Career Development Award Agency: AMRAA	05/03/18	09/26/18
DoD Lung Cancer, Idea Development Award Agency: AMRAA	05/03/18	09/26/18
DoD Lung Canceer, Investigator-Initiated Translational Research Award Agency: AMRAA	05/03/18	09/26/18
DoD Lung Cancer, Translational Research Partnership Award Agency: AMRAA	05/03/18	09/26/18
DoD Peer Reviewed Cancer, Career Development Award Agency: AMRAA	05/02/18	09/26/18
DoD Peer Reviewed Cancer, Idea Award with Special Focus Agency: AMRAA	05/02/18	09/26/18
DoD Peer Reviewed Cancer, Translational Team Science Award Agency: AMRAA	05/02/18	09/26/18
DoD Peer Reviewed Cancer, Impact Award Agency: AMRAA	05/02/18	09/26/18
Comprehensive Partnerships to Advance Cancer Health Equity (CPACHE) (Collaborative U54 Clinical Trial Optional) Agency: NIH Institutions: NCI	04/30/18	01/09/20
Improving the Reach and Quality of Cancer Care in Rural Populations (R01 Clinical Trial Required) Agency: NIH Institutions: NCI	04/27/18	09/19/18
Harnessing Big Data to Halt HIV (R01 Clinical Trial Optional) Agency: NIH Institutions: NIAIDNCINIMH	04/20/18	05/07/21
DoD Ovarian Cancer Clinical Development Award Agency: AMRAA	04/11/18	08/08/18
DoD Ovarian Cancer, Ovarian Cancer Academy- Early-Career Investigator Award Agency: AMRAA	04/11/18	08/08/18
DoD Ovarian Cancer, Omics Consortium Development Award Agency: AMRAA	04/11/18	08/08/18
DoD Ovarian Cancer Pilot Award Agency: AMRAA	04/11/18	08/22/18
DoD Ovarian Cancer Investigator-Initiated Research Award Agency: AMRAA	04/11/18	08/22/18
Lasker Clinical Research Scholars Program (Si2/R00 Clinical Trial Optional) Agency: NIH Institutions: NCINEINHLBINIANIAIDNIAMSNICHDNIDCRNIDDKNIDANIEHSNIMHNINDSNINRNIMHD	04/03/18	08/31/18
Revision Applications to National Cancer Institute (NCI) supported U01 Awards to Include Research on the NCIs Provocative Questions (U01 Clinical Trial Optional) Agency: NIH Institutions: NCI	04/03/18	10/30/18
Revision Applications to National Cancer Institute (NCI) Supported R01 Awards to Include Research on the NCIs Provocative Questions (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	04/03/18	10/30/18
Revision Applications to National Cancer Institute (NCI)-supported P01 Awards to Include Research on the NCIs Provocative Questions (P01 Clinical Trial Optional) Agency: NIH Institutions: NCI	04/03/18	10/30/18
Revision Applications to National Cancer Institute (NCI)-supported P50 Awards to Include Research on the NCIs Provocative Questions (P50 Clinical Trial Optional) Agency: NIH Institutions: NCI	04/03/18	10/30/18
Age-related Microbiota Changes and their Implications in Chronic Disease Prevention, Treatment and Progression (R01 Clinical Trial Optional). Agency: NIH Institutions: NCINIANIDCRNINR	04/03/18	05/07/21
Age-related Microbiota Changes and their Implications in Chronic Disease Prevention, Treatment and Progression (R21 Clinical Trial Optional). Agency: NIH Institutions: NCINIANIDCRNINR	04/03/18	05/07/21
Small Research Grants for Analyses of Data for the Gabriella Miller Kids First Data Resource (R03 - Clinical Trial Not Allowed) Agency: NIH Institutions: NICHDNHLBINIAAANIDCRNINDS	03/30/18	09/07/19
Food Specific Molecular Profiles and Biomarkers of Food and Nutrient Intake, and Dietary Exposure (R01 Clinical Trial Optional) Agency: NIH Institutions: NIDDKNCINCCIHODS	03/29/18	09/27/19
Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research (R21 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	03/29/18	11/19/20
Reducing Stigma to Improve HIV/AIDS Prevention, Treatment and Care in Low and Middle- Income Countries (R21 Clinical Trial Optional) Agency: NIH Institutions: FICNIMHNCINICHDOBSSR	03/29/18	08/01/18
Improving Patient Adherence to Treatment and Prevention Regimens to Promote Health (R21 Clinical Trial Optional) Agency: NIH Institutions: OBSSRNCINIANIAAANIAIDNIDANIMHNINRNIMHD	03/28/18	05/07/21
Improving Patient Adherence to Treatment and Prevention Regimens to Promote Health (R01 Clinical Trial Optional) Agency: NIH Institutions: OBSSRNCINIANIAAANIAIDNIDANIMHNINRNIMHDNCCIH	03/28/18	05/07/21
Research on the Health of Transgender and Gender Nonconforming Populations (R21 Clinical Trial Optional) Agency: NIH Institutions: NICHDNCINHGRINIANIAAANIAIDNIDCDNIEHSNIMHDNIMHNINRSGMROOARORWH	03/28/18	01/07/21
Research on the Health of Transgender and Gender Nonconforming Populations (R01 Clinical Trial Optional) Agency: NIH Institutions: NICHDNCINHGRINIANIAAANIAIDNIDCDNIEHSNIMHDNIMHNINRSGMROOARORWH	03/28/18	01/07/21
Exploratory/Developmental Clinical Research Grants in Obesity (R21 Clinical Trial Optional) Agency: NIH Institutions: NIDDKNCINICHDODS	03/27/18	05/07/21
DoD Breast Cancer, Innovator Award Agency: AMRAA	03/27/18	08/14/18
DoD Breast Cancer, Breakthrough Award Levels 3 and 4 Agency: AMRAA	03/27/18	08/14/18
DoD Breast Cancer, Distinguished Investigator Award Agency: AMRAA	03/27/18	08/14/18
Fiscal Year (FY) 2019 Department of Defense Multidisciplinary Research Program of the University Research Initiative (MURI) - ARMY SUBMISSION Agency: AMC	03/27/18	10/16/18
Fogarty HIV Research Training Program for Low-and Middle-Income Country Institutions (D43 Clinical Trial Optional) Agency: NIH Institutions: FICNCINIAAANIDANIMH	03/21/18	08/23/18
Research Answers to National Cancer Institute's (NCI) Provocative Questions (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	03/09/18	10/30/18
Research Answers to National Cancer Institute's (NCI) Provocative Questions (R21 Clinical Trial Optional) Agency: NIH Institutions: NCI	03/09/18	10/30/18
SBIR Technology Transfer (R43/R44 Clinical Trial Not Allowed) Agency: NIH Institutions: NINDSNCINEINIAAANIDCRNIDANINR	03/06/18	04/05/21
Short-term Mentored Career Enhancement Awards for Mid-Career Investigators to Integrate Basic Behavioral and Social Sciences (K18 Clinical Trial Required) Agency: NIH Institutions: OppNetNCINIANIDCDNCCIHOBSSR	03/02/18	04/13/19
Fundamental Mechanisms of Affective and Decisional Processes in Cancer Control (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	02/27/18	10/11/19
Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R21 - Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	02/23/18	05/07/21
Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R01 - Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	02/23/18	05/07/21
U.S. Tobacco Control Policies to Reduce Health Disparities (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	02/21/18	06/15/20
U.S. Tobacco Control Policies to Reduce Health Disparities (R21 Clinical Trial Optional) Agency: NIH Institutions: NCI	02/21/18	06/15/20
Smart and Connected Health Agency: NSF	02/21/18	12/11/18
Ruth L. Kirschstein National Research Service Award (NRSA)Individual Fellowship for Students at Institutions Without NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30) Agency: NIH Institutions: NCINEINHGRINIANIAAANIAIDNIAMSNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNIMHDNLMNCCIHORIP	02/20/18	01/07/21
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Senior Fellowship (Parent F33) Agency: NIH Institutions: NCINIANIAAANIAMSNIDCRNIDANIEHSNIGMSNINR	02/20/18	01/07/21
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions with NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30) Agency: NIH Institutions: NCINEINHGRINIANIAAANIAIDNICHDNIDCDNIDCRNIDDKNIDANIEHSNIMHNIMHDNCCIHORIP	02/16/18	01/07/21
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship (Parent F31) Agency: NIH Institutions: NCINEINHGRINIANIAAANIAIDNIAMSNICHDNIDCDNIDCRNIDANIDDKNIEHSNIMHNINDSNINRNIMHDNCCIH	02/16/18	01/07/21
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (Parent F32) Agency: NIH Institutions: NCINEINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDANIDDKNIEHSNIGMSNIMHNINRNIMHDNCCIH	02/16/18	01/07/21
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship to Promote Diversity in Health-Related Research (Parent F31) Agency: NIH Institutions: NCINEINHGRINIANIAAANIAIDNIAMSNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNLMNIMHNINDSNINRNIMHDNCCIHORIP	02/15/18	01/07/21
Immune System Engineering For Targeted Tolerance in Type 1 Diabetes (R01 Clinical Trial Not Allowed) Agency: NIH Institutions: NIDDKNIAID	02/14/18	12/06/18
SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Focused Technologies Toward Commercialization (R44 Clinical Trial Optional) Agency: NIH Institutions: NCI	02/14/18	08/15/18
Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	02/13/18	11/19/20
Basic Research in Cancer Health Disparities (R01 Clinical Trials Not Allowed) Agency: NIH Institutions: NCI	02/13/18	11/19/20
NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed) Agency: NIH Institutions: NCINEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNINDSNIMHDNLMNCCIHNCATSORIP	02/09/18	01/07/21
Advanced-Stage Development and Utilization of Research Infrastructure for Interdisciplinary Aging Studies (R33 - Clinical Trial Optional) Agency: NIH Institutions: NIANCI	02/08/18	09/07/19
Research Infrastructure Development for Interdisciplinary Aging Studies (R21/R33 - Clinical Trial Optional) Agency: NIH Institutions: NIANCI	02/08/18	09/07/19
Perception and Cognition Research to Inform Cancer Image Interpretation (R21 Clinical Trial Optional) Agency: NIH Institutions: NCINIBIB	02/07/18	09/26/19
Perception and Cognition Research to Inform Cancer Image Interpretation (R01 Clinical Trial Optional) Agency: NIH Institutions: NCINIBIB	02/07/18	09/26/19
Innovative Approaches to Studying Cancer Communication in the New Media Environment (R01 - Clinical Trial Optional) Agency: NIH Institutions: NCI	02/07/18	06/13/19
Innovative Approaches to Studying Cancer Communication in the New Media Environment (R21 - Clinical Trial Optional) Agency: NIH Institutions: NCI	02/07/18	06/13/19
Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	02/05/18	05/07/21
Traceback Testing: Increasing Identification and Genetic Counseling of Mutation Carriers through Family-based Outreach (U01 Clinical Trial Optional) Agency: NIH Institutions: NCI	02/01/18	07/05/19
Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	01/30/18	04/11/19
Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment (R21 Clinical Trial Optional) Agency: NIH Institutions: NCI	01/30/18	04/11/19
Successor-in-Interest (Type 6 Parent Clinical Trial Optional) Agency: NIH Institutions: NCINEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMFICNCCIHNCATSORIPOBSSRORWH	01/26/18	01/25/21
Change of Grantee Organization (Type 7 Parent Clinical Trial Optional) Agency: NIH Institutions: NCINEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMFICNCCIHNCATSORIPOBSSRORWH	01/25/18	01/25/21
Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp - Clinical Trial Optional) Agency: NIH Institutions: NCINEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMFICNCCIHNCATSORIPOBSSRORWH	01/25/18	01/25/21
Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp - Clinical Trial Not Allowed ) Agency: NIH Institutions: ORWHNCINEINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMNCCIHORIP	01/25/18	09/07/21
Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) Agency: NIH Institutions: NCINEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMFICNCCIHNCATSORIP	01/24/18	09/07/21
PHS 2018-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) Agency: NIH Institutions: NCINEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMNCCIHNCATSORIP	01/16/18	04/05/19
PHS 2018-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required) Agency: NIH Institutions: NCINEINHLBINHGRINIANIAAANICHDNIDCDNIDCRNIDANIGMSNIMHNINRNIMHDNCCIH	01/16/18	04/05/19
PHS 2018-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required) Agency: NIH Institutions: NCINEINHLBINHGRINIANIAAANICHDNIDCDNIDCRNIDANIGMSNIMHNINRNIMHDNCCIH	01/16/18	04/05/19
PHS 2018-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed) Agency: NIH Institutions: NCINEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMNCCIHNCATSORIP	01/16/18	04/05/19
Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required) Agency: NIH Institutions: NCI	01/05/18	01/07/21
National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trials Required) Agency: NIH Institutions: NCI	01/05/18	01/07/21
Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Optional) Agency: NIH Institutions: NCINIDCRNIBIB	12/21/17	01/07/21
Research on the Mechanisms and/or Behavioral Outcomes of Multisensory Processing (R01 - Clinical Trial Optional) Agency: NIH Institutions: NIANCINEINICHDNIDCDNIDANINDSNCCIHOBSSR	12/21/17	01/07/19
International Research Scientist Development Award (IRSDA) (K01) - Independent Clinical Trial Not Allowed Agency: NIH Institutions: FICNCI	12/21/17	03/06/20
International Research Scientist Development Award (IRSDA) (K01) - Independent Clinical Trial Required Agency: NIH Institutions: FICNCI	12/21/17	03/06/20
Early-life Factors and Cancer Development Later in Life (R03 - Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	12/20/17	01/07/21
Early-life Factors and Cancer Development Later in Life (R21 - Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	12/20/17	01/07/21
Early-life Factors and Cancer Development Later in Life (R01 - Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	12/20/17	01/07/21
Advancing the Science of Geriatric Palliative Care (R21 - Clinical Trial Optional) Agency: NIH Institutions: NIANINRNIMHDNCI	12/15/17	05/07/20
Advancing the Science of Geriatric Palliative Care (R01 - Clinical Trial Optional) Agency: NIH Institutions: NIANCCIHNINRNIMHDNCINHLBI	12/15/17	05/07/20
Synthetic Biology for Engineering Applications (R01) (Clinical Trial Optional) Agency: NIH Institutions: NIBIBNCINCCIH	12/15/17	09/07/20
Academic Research Enhancement Award (Parent R15 Clinical Trial Not Allowed) Agency: NIH Institutions: NCINEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNIMHDNINDSNINRNLMNCCIHORIPICs	12/13/17	01/07/21
Using Information Technology to Support Systematic Screening and Treatment of Depression in Cancer (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	12/11/17	05/07/21
Using Information Technology to Support Systematic Screening and Treatment of Depression in Cancer (R21 Clinical Trial Optional) Agency: NIH Institutions: NCI	12/11/17	05/07/21
NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed) Agency: NIH Institutions: NCINEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMNCCIHORIPICs	12/06/17	01/07/21
The NCI Transition Career Development Award (K22 - Independent Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	12/06/17	03/12/21
The NCI Transition Career Development Award (K22 Independent Clinical Trial Required) Agency: NIH Institutions: NCI	12/06/17	03/12/21
Developing the Therapeutic Potential of the Endocannabinoid System for Pain Treatment (R01, Clinical Trial Optional) Agency: NIH Institutions: NIDANCINIANCCIHNINDSNIAAANICHD	12/06/17	09/07/18
Cancer Research Education Grants Program - Curriculum or Methods Development (R25) Agency: NIH Institutions: NCI	12/05/17	01/07/21
Cancer Research Education Grants Program - Research Experiences (R25) Agency: NIH Institutions: NCI	12/05/17	01/07/21
Cancer Research Education Grants Program - Courses for Skills Development (R25) Agency: NIH Institutions: NCI	12/05/17	01/07/21
Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U54 Clinical Trials Optional) Agency: NIH Institutions: NCI	12/04/17	09/28/18
Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P01 Clinical Trials Optional) Agency: NIH Institutions: NCI	12/04/17	09/28/18
Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trials Optional) Agency: NIH Institutions: NCI	12/04/17	09/28/18
Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U01 Clinical Trials Optional) Agency: NIH Institutions: NCI	12/04/17	09/28/18
Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trials Optional) Agency: NIH Institutions: NCI	12/04/17	09/28/18
Mobile Health: Technology and Outcomes in Low and Middle Income Countries (R21 Clinical Trial Optional) Agency: NIH Institutions: FICNCINIBIBNIDCDNIMHOBSSRNICHD	11/30/17	08/31/18
Image-guided Drug Delivery (R01 Clinical Trial Optional) Agency: NIH Institutions: NCINIBIB	11/30/17	11/22/18
Multi-Site Studies for System-Level Implementation of Substance Use Prevention and Treatment Services (R01 Clinical Trial Optional) Agency: NIH Institutions: NIDANCINIAAA	11/30/17	11/13/20
Improving Smoking Cessation in Socioeconomically Disadvantaged Populations via Scalable Interventions (R21 Clinical Trial Optional) Agency: NIH Institutions: NCI	11/30/17	06/13/19
Improving Smoking Cessation in Socioeconomically Disadvantaged Populations via Scalable Interventions (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	11/30/17	06/13/19
Exploratory/Developmental Surgical Disparities Research (R21 Clinical Trial Optional) Agency: NIH Institutions: NIMHDNCINIAMSORWH	11/30/17	06/07/19
Surgical Disparities Research (R01 Clinical Trial Optional) Agency: NIH Institutions: NIMHDNCINIAMSORWHNINRNICHD	11/30/17	06/07/19
Multidisciplinary Studies of HIV/AIDS and Aging (R01 Clinical Trial Optional) Agency: NIH Institutions: NIANCINCCIHNIDCRNIDANIMHNIMHDNINDSNINR	11/29/17	09/07/20
Multidisciplinary Studies of HIV/AIDS and Aging (R21 Clinical Trial Optional) Agency: NIH Institutions: NIANCINIAAANIDCRNIDDKNIDANIMHNIMHDNINDSNINR	11/29/17	09/07/20
Quantitative Imaging Tools and Methods for Cancer Therapy Response Assessment (UG3/UH3 Clinical Trial Optional) Agency: NIH Institutions: NCI	11/29/17	01/09/20
Quantitative Imaging Tools and Methods for Cancer Response Assessment (U01 Clinical Trial Optional) Agency: NIH Institutions: NCI	11/29/17	01/09/20
NIH Pathway to Independence Award (Parent K99/R00 - Clinical Trial Required) Agency: NIH Institutions: NCINEINHLBINHGRINIANIAAANIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIMHNINDSNINRNIMHDNCCIHNIEHS	11/29/17	01/07/21
NIH Pathway to Independence Award (Parent K99/R00 - Independent Clinical Trial Not Allowed) Agency: NIH Institutions: NCINEINHLBINHGRINIANIAAANIAMSNIAIDNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINRNIMHDNLMNCCIHNINDSORIP	11/29/17	01/07/21
Tobacco Use and HIV in Low and Middle Income Countries (R21 Clinical Trial Optional) Agency: NIH Institutions: NCINIDA	11/28/17	01/07/20
Tobacco Use and HIV in Low and Middle Income Countries (R01 Clinical Trial Optional) Agency: NIH Institutions: NCINIDA	11/28/17	01/07/20
Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	11/28/17	04/11/19
Predicting Behavioral Responses to Population-Level Cancer Control Strategies (R21 Clinical Trial Optional) Agency: NIH Institutions: NCI	11/28/17	04/11/19
Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R21 Clinical Trial Optional) Agency: NIH Institutions: NCI	11/28/17	04/11/19
Population Health Interventions: Integrating Individual and Group Level Evidence (R01) - Clinical Trial Optional Agency: NIH Institutions: NCINIDCDNIDAOBSSR	11/22/17	05/07/19
Population Health Interventions: Integrating Individual and Group Level Evidence (R21) - Clinical Trials Optional Agency: NIH Institutions: OBSSRNCINIDCDNIDA	11/22/17	05/07/19
Education and Health: New Frontiers (R03) - Clinical Trial Optional Agency: NIH Institutions: OBSSRNCINIANICHDNIDA	11/22/17	01/07/19
Education and Health: New Frontiers (R01)- Clinical Trial Optional Agency: NIH Institutions: OBSSRNCINIANICHDNIDA	11/22/17	01/07/19
Education and Health: New Frontiers (R21)- Clinical Trial Optional Agency: NIH Institutions: OBSSRNCINIANICHDNIDA	11/22/17	01/07/19
Population Health Interventions: Integrating Individual and Group Level Evidence (R21)- Clinical Trials Not Allowed Agency: NIH Institutions: OBSSRNCINIDCRNIDCD	11/21/17	05/07/19
Population Health Interventions: Integrating Individual and Group Level Evidence (R01) Clinical Trials Not Allowed Agency: NIH Institutions: NCINIDCRNIDCDOBSSR	11/21/17	05/07/19
Research To Address Sleep Disorders in the Context of Medical Rehabilitation (R01 Clinical Trial Optional) Agency: NIH Institutions: NICHDNINR	11/21/17	03/29/19
NCI Small Grants Program for Cancer Research (NCI Omnibus R03 Clinical Trial Optional) Agency: NIH Institutions: NCI	11/21/17	01/07/20
Methodology and Measurement in the Behavioral and Social Sciences (R21) Clinical Trials Optional Agency: NIH Institutions: OBSSRNCINEINIANIAAANIDCDNCCIHODPORWHOBSSR	11/21/17	09/07/19
Methodology and Measurement in the Behavioral and Social Sciences (R01) Clinical Trials Optional Agency: NIH Institutions: OBSSRNCINEINIANIAAANIDCDNCCIHODPORWH	11/21/17	09/07/19
Mentored Clinical Scientist Research Career Development Award (Parent K08 - Independent Clinical Trial Required) Agency: NIH Institutions: NCINEINHLBINHGRINIANIAAANIBIBNICHDNIDCDNIDCRNIDDKNIDANIMHNINDSNIMHDNCCIHNIEHS	11/21/17	01/07/21
Mentored Clinical Scientist Research Career Development Award (Parent K08 - No Independent Clinical Trials) Agency: NIH Institutions: NCINEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNIMHDNCCIHNINDS	11/21/17	01/07/21
Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32) Agency: NIH Institutions: NCINEINHGRINIANIAIDNIAMSNIBIBNICHDNIDCDNIDDKNIDANIEHSNIGMSNIMHNINRNCCIHNHLBIORIPNINDSNIAAA	11/21/17	01/07/21
NCI Transition Career Development Award to Promote Diversity (K22 - No Clinical Trials) Agency: NIH Institutions: NCI	11/20/17	01/07/21
NCI Transition Career Development Award to Promote Diversity (K22 Clinical Trial Required) Agency: NIH Institutions: NCI	11/20/17	01/07/21
Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21 - Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	11/20/17	09/28/18
Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 - Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	11/20/17	09/28/18
Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R21 - Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	11/20/17	09/28/18
Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 - Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	11/20/17	09/28/18
NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional) Agency: NIH Institutions: NCI	11/17/17	03/22/19
Integrative Research on Polysubstance Abuse and Addiction (R21/R33 Clinical Trial Optional) Agency: NIH Institutions: NIDANIAAANCI	11/17/17	09/07/19
Target Assessment, Engagement and Data Replicability to Improve Substance Use Disorders Treatment Outcomes (R33 Clinical Trial Optional) Agency: NIH Institutions: NIDANCINIAAA	11/17/17	09/07/19
Target Assessment, Engagement and Data Replicability to Improve Substance Use Disorders Treatment Outcomes (R21/R33 Clinical Trial Optional) Agency: NIH Institutions: NIDANCINIAAA	11/17/17	09/07/19
NCI Mentored Research Scientist Development Award to Promote Diversity (K01) Agency: NIH Institutions: NCI	11/17/17	01/07/21
NCI Mentored Research Scientist Development Award to Promote Diversity (K01) Agency: NIH Institutions: NCI	11/17/17	01/07/21
Fertility Status as a Marker for Overall Health (R21 Clinical Trial Optional) Agency: NIH Institutions: NICHDNIEHSODP	11/15/17	05/07/20
Stimulating Innovations in Behavioral Intervention Research for Cancer Prevention and Control (R21 Clinical Trial Optional) Agency: NIH Institutions: NCI	11/15/17	05/07/19
Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional) Agency: NIH Institutions: NCINICHDNIDANIAMS	11/13/17	01/07/19
Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	11/08/17	07/05/19
Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R21 Clinical Trial Optional) Agency: NIH Institutions: NCI	11/08/17	07/16/19
Palliative Care Needs of Individuals with Advanced Rare Diseases and Their Family Caregivers (R01 Clinical Trial Optional) Agency: NIH Institutions: NINRNCI	11/07/17	01/07/20
Palliative Care Needs of Individuals with Rare Advanced Diseases and Their Family Caregivers (R21 Clinical Trial Optional) Agency: NIH Institutions: NINRNCI	11/07/17	01/07/20
Bioengineering Research Partnerships (U01 Clinical Trial Optional) Agency: NIH Institutions: NIBIBNCINEINIAAANICHDNIDANIEHSNINDS	11/07/17	01/07/19
Short-term Mentored Career Enhancement Awards for Mid-Career Investigators to Integrate Basic Behavioral and Social Sciences (K18 - No Independent Clinical Trials) Agency: NIH Institutions: OppNetNCINIDCRNIDCDNIANIDANIMHDNCCIHOBSSR	11/07/17	03/06/19
Mechanisms, Models, Measurement, and Management in Pain Research (R01 Clinical Trial Optional) Agency: NIH Institutions: NINRNIANIAMSNIDDKNIDANIDCRNINDSNCCIHNIMHD	11/07/17	05/07/19
Bioengineering Research Grants (BRG) (R01 Clinical Trial Optional) Agency: NIH Institutions: NIBIBNCINEINHGRINIAIDNIAMSNICHDNIDANIEHSNINDS	11/07/17	05/07/19
Mechanisms, Models, Measurement, and Management in Pain Research (R21 Clinical Trial Optional) Agency: NIH Institutions: NCININRNIANIAMSNIDANIDCRNINDSNCCIHNIMHD	11/07/17	05/07/19
Research to Advance the Understanding and Management of the Multiple Organ Dysfunction Syndrome in Children (R01 Clinical Trial Optional) Agency: NIH Institutions: NICHD	11/06/17	05/07/19
End-of-Life and Palliative Needs of Adolescents and Young Adults (AYA) with Serious Illnesses (R01 Clinical Trial Optional) Agency: NIH Institutions: NINRNCINICHDORWH	11/06/17	01/07/19
End-of-Life and Palliative Needs of Adolescents and Young Adults (AYA) with Serious Illnesses (R21 Clinical Trial Optional) Agency: NIH Institutions: NINRNCINICHDORWH	11/06/17	01/07/19
The Health of Sexual and Gender Minority (SGM) Populations (R01 Clinical Trial Optional) Agency: NIH Institutions: NICHDNCINIAAANIAIDNIDCDNIDCRNIDANIMHNIMHDOBSSR	11/06/17	09/07/18
The Health of Sexual and Gender Minority (SGM) Populations (R21 Clinical Trial Optional) Agency: NIH Institutions: NICHDNCINIAIDNIDANIDCDNIDCRNIMHNIMHDOBSSR	11/06/17	09/07/18
The Health of Sexual and Gender Minority (SGM) Populations (R03 Clinical Trial Optional) Agency: NIH Institutions: NICHDNCINIAIDNIDANIDCRNIMHNIMHDOBSSR	11/06/17	09/07/18
The Health of Sexual and Gender Minority (SGM) Populations (R15 Clinical Trial Optional) Agency: NIH Institutions: NICHDNCINIAIDNIDANIDCDNIDCRNIMHNIMHD	11/06/17	09/07/18
Early Phase Clinical Trials in Imaging and Image-Guided Interventions (R01 Clinical Trial Required) Agency: NIH Institutions: NCI	11/06/17	02/14/20
Reducing Overscreening for Breast, Cervical, and Colorectal Cancers among Older Adults (R21 Clinical Trial Optional) Agency: NIH Institutions: NCINIA	11/03/17	01/07/20
Oral Anticancer Agents: Utilization, Adherence, and Health Care Delivery (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	11/03/17	01/07/20
Reducing Overscreening for Breast, Cervical, and Colorectal Cancers among Older Adults (R01 Clinical Trial Optional) Agency: NIH Institutions: NCINIA	11/03/17	01/07/20
Oral Anticancer Agents: Utilization, Adherence, and Health Care Delivery (R21 Clinical Trial Optional) Agency: NIH Institutions: NCI	11/03/17	01/07/20
Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	11/03/17	09/07/18
Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R21 Clinical Trial Optional) Agency: NIH Institutions: NCI	11/03/17	09/07/18
Dissemination and Implementation Research in Health (R01 Clinical Trial Optional) Agency: NIH Institutions: NCINHLBINHGRINIANIAAANIAIDNICHDNIDCDNIDCRNIDANIEHSNIMHNINDSNINRNIMHDNCCIHODPOBSSR	11/03/17	05/07/19
Dissemination and Implementation Research in Health (R21 Clinical Trial Optional) Agency: NIH Institutions: NCINHGRINIANIAAANIAIDNICHDNIDCDNIDCRNIDANIEHSNIMHNINDSNINRNCCIHODPOBSSRNIMHD	11/03/17	05/07/19
Examination of Survivorship Care Planning Efficacy and Impact (R21 Clinical Trial Optional) Agency: NIH Institutions: NCI	11/02/17	01/07/19
Revision Applications for Validation of Mobile/Wireless Health Tools for Measurement and Intervention (R01) Clinical Trial Optional Agency: NIH Institutions: OBSSRNCINIBIBNIDCD	11/02/17	01/07/19
Examination of Survivorship Care Planning Efficacy and Impact (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	11/02/17	01/07/19
Improving Outcomes in Cancer Treatment-Related Cardiotoxicity (R01 Clinical Trial Optional) Agency: NIH Institutions: NCINHLBI	11/02/17	01/07/19
Improving Outcomes in Cancer Treatment-Related Cardiotoxicity (R21 Clinical Trial Optional) Agency: NIH Institutions: NCINHLBI	11/02/17	01/07/19
NCCIH Mind and Body Clinical Trial Cooperative Agreement (U01 Clinical Trial Required) Agency: NIH Institutions: NCCIH	11/02/17	02/29/20
Potential Effects of Metformin on Aging and Age-Related Conditions: Small-Scale Clinical Studies and Secondary Analysis of Controlled Clinical Studies (R01 Clinical Trial Optional) Agency: NIH Institutions: NIANCI	11/01/17	05/07/20
Nutrigenetics and Nutrigenomics Approaches for Nutrition Research (R01 Clinical Trial Optional) Agency: NIH Institutions: NIDDKNCINCCIHODS	11/01/17	09/07/19
Addressing Health Disparities through Effective Interventions Among Immigrant Populations (R01 Clinical Trial Optional) Agency: NIH Institutions: NIMHDNCINIAAANIDANIEHS	11/01/17	01/07/20
Addressing Health Disparities through Effective Interventions Among Immigrant Populations (R21 Clinical Trial Optional) Agency: NIH Institutions: NIMHDNCINIAAANIDANIEHS	11/01/17	01/07/20
Academic-Industrial Partnerships to Translate and Validate in vivo Cancer Imaging Systems (R01 Clinical Trial Optional) Agency: NIH Institutions: NCINIDCRNIDDK	11/01/17	11/05/19
Accelerating the Pace of Drug Abuse Research Using Existing Data (R01 Clinical Trial Optional) Agency: NIH Institutions: NIDANCINIAAA	11/01/17	05/07/19
NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 - No Independent Clinical Trials) Agency: NIH Institutions: NCI	10/31/17	01/07/21
NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 - Clinical Trials Required) Agency: NIH Institutions: NCI	10/31/17	01/07/21
National Cancer Institute Program Project Applications (P01 Clinical Trial Optional) Agency: NIH Institutions: NCI	10/30/17	01/07/20
Simulation Modeling and Systems Science to Address Health Disparities (R01-Clinical Trial Not Allowed) Agency: NIH Institutions: NIMHDNCINHLBINIANIDCDNIDANIMHNLMODPOBSSRNIAAA	10/20/17	06/07/19
Testing Interventions for Health-Enhancing Physical Activity (R01 - Clinical Trial Optional) Agency: NIH Institutions: ODPNCINIANIAAANICHDNIDANIMHDNCCIH	10/17/17	01/07/21
Specialized Programs of Research Excellence (SPOREs) in Human Cancers for years 2018, 2019 and 2020 (P50) Agency: NIH Institutions: NCINIDCR	10/12/17	01/07/21
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 - Clinical Trials Not Allowed Agency: NIH Institutions: NCI	10/12/17	10/08/20
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 - Clinical Trials Not Allowed) Agency: NIH Institutions: NCI	10/12/17	10/08/20
Developing Interventions for Health-Enhancing Physical Activity (R21/R33 - Clinical Trial Optional) Agency: NIH Institutions: ODPNCINIANIAAANIDANCCIH	10/10/17	01/07/21
Innovative Molecular Analysis Technology Development for Cancer Research and Clinical Care (R43/R44 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	10/03/17	01/07/21
Multilevel Interventions in Cancer Care Delivery: Follow-up to Abnormal Screening Tests (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	09/29/17	01/07/21
Research to Improve Native American Health (R21 Clinical Trial Optional) Agency: NIH Institutions: NCINIAAANIDANIEHSNIMHNIMHDOBSSRNIDCR	09/29/17	05/14/20
Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) Agency: NIH Institutions: NCINIAAANIDANIEHSNIMHNIMHDOBSSRNINRNIDCR	09/29/17	05/14/20
Short-term Mentored Career Enhancement Awards for Mid-Career Investigators to Integrate Basic Behavioral and Social Sciences (K18) Agency: NIH Institutions: OppNetNCINIDCRNIDCDNIDANIMHDNCCIHOBSSRNIA	09/19/17	03/06/19
Collaborative Minority Health and Health Disparities Research with Tribal Epidemiology Centers (R01) Agency: NIH Institutions: NIMHDNCINIAAANIDANIEHS	09/13/17	12/04/19
Collaborative Minority Health and Health Disparities Research with Tribal Epidemiology Centers (R21) Agency: NIH Institutions: NIMHDNCINIAAANIDANIEHS	09/13/17	12/04/19
Clinical and Epidemiological Research on Chronic Disease in the Caribbean (R01) Agency: NIH Institutions: NIMHDNCINHLBINIANINR	08/25/17	11/15/19
Stimulating Access to Research in Residency (StARR) (R38) Agency: NIH Institutions: NHLBINCINIAID	08/23/17	01/24/20
Biology of Lung, and Head and Neck Preneoplasias (R21) Agency: NIH Institutions: NCI	08/16/17	01/07/21
Biology of Lung, and Head and Neck Preneoplasias (R01) Agency: NIH Institutions: NCI	08/15/17	01/07/21
The Interplay of Cell Death Pathways in Cancer Cell Survival and Resistance to Therapy (R01) Agency: NIH Institutions: NCI	08/04/17	09/07/20
The Interplay of Cell Death Pathways in Cancer Cell Survival and Resistance to Therapy (R21) Agency: NIH Institutions: NCI	08/04/17	09/07/20
Ethical, Legal, and Social Implications (ELSI) of Genomics Small Research Grant Program (R03) Agency: NIH Institutions: NHGRINCINIANIAIDNICHDNIDCDNIEHSFIC	08/01/17	09/07/20
Ethical, Legal, and Social Implications (ELSI) of Genomics Research Project Grant Program (R01) Agency: NIH Institutions: NHGRINCINIANICHDNIEHSNINDSNIMHD	08/01/17	09/07/20
Ethical, Legal, and Social Implications (ELSI) of Genomics Exploratory/Developmental Research Grant Program (R21) Agency: NIH Institutions: NHGRINCINIANIAIDNICHDNIDCDNIEHSNINDSNIMHD	08/01/17	09/07/20
Assay development and screening for discovery of chemical probes or therapeutic agents (R01) Agency: NIH Institutions: NCINIAIDNIDCDNIDANIMH	07/27/17	09/07/20
Using Small Molecules and Molecular Genetics to Identify Novel Targets and Mechanisms Contributing to Tumor Immune Evasion (R01) Agency: NIH Institutions: NCI	07/20/17	09/07/20
Discovery of Small Molecule Immunomodulators for Cancer Therapy (R01) Agency: NIH Institutions: NCI	07/20/17	09/07/20
2017 Human Exploration Research Opportunities (HERO) Agency: JSC	07/06/17	09/07/18
Multidisciplinary Studies of HIV/AIDS and Aging (R21) Agency: NIH Institutions: NIANCINIAAANIAMSNIDCRNIDANIMHNIMHDNINDSNINR	06/23/17	09/07/20
Multidisciplinary Studies of HIV/AIDS and Aging (R01) Agency: NIH Institutions: NIANCINCCIHNIAMSNIDCRNIDANIMHNIMHDNINDSNINR	06/23/17	09/07/20
Integration of Individual Residential Histories into Cancer Research (R21) Agency: NIH Institutions: NCI	06/22/17	09/07/20
Integration of Individual Residential Histories into Cancer Research (R01) Agency: NIH Institutions: NCI	06/22/17	09/07/20
HIV/AIDS and the Tumor Niche (R01) Agency: NIH Institutions: NCI	05/26/17	08/07/18
Leveraging Population-based Cancer Registry Data to Study Health Disparities (R01) Agency: NIH Institutions: NCI	05/16/17	09/07/20
Leveraging Population-based Cancer Registry Data to Study Health Disparities (R21) Agency: NIH Institutions: NCI	05/16/17	09/07/20
In Vitro and Animal Model Studies on HBV/HIV Co-Infection (R01) Agency: NIH Institutions: NIAIDNCINIAAA	05/12/17	05/07/20
HIV and Hepatitis B Co-Infection: Advancing HBV Functional Cure through Clinical Research (R01) Agency: NIH Institutions: NIAIDNCINIAAA	05/12/17	05/07/20
In Vitro and Animal Model Studies on HBV/HIV Co-Infection (R21) Agency: NIH Institutions: NIAIDNCINIAAA	05/12/17	05/07/20
HIV and Hepatitis B Co-Infection: Advancing HBV Functional Cure through Clinical Research (R21) Agency: NIH Institutions: NIAIDNCINIAAA	05/12/17	05/07/20
Genomic Community Resources (U24) Agency: NIH Institutions: NHGRINCI	05/08/17	01/25/20
Collaborative Research Projects to Enhance Applicability of Mammalian Models for Translational Research (Collaborative R01) Agency: NIH Institutions: NCI	04/04/17	05/07/20
Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01) Agency: NIH Institutions: NCI	04/03/17	05/07/20
Innovative Research in Cancer Nanotechnology (IRCN) (R01) Agency: NIH Institutions: NCI	03/30/17	05/21/20
Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R01) Agency: NIH Institutions: NCINHGRINIDCR	03/30/17	05/07/20
Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R21) Agency: NIH Institutions: NCINHGRINIDCR	03/30/17	05/07/20
Centers for AIDS Research (P30) Agency: NIH Institutions: NCINHLBINIANIAIDNICHDNIDCRNIDDKNIDANIGMSNIMHNIMHDFIC	03/30/17	08/17/19
Developmental Centers for AIDS Research (P30) Agency: NIH Institutions: NCINHLBINIANIAIDNICHDNIDCRNIDDKNIDANIGMSNIMHNIMHDFIC	03/30/17	08/17/19
Mechanisms and Consequences of Sleep Disparities in the U.S. (R21) Agency: NIH Institutions: NIMHDNCINIANIAAANCCIHORWHNIDA	03/29/17	07/11/19
Mechanisms and Consequences of Sleep Disparities in the U.S. (R01) Agency: NIH Institutions: NIMHDNCINHLBINIANIAAANINRNCCIHORWHNIDA	03/29/17	07/11/19
Core Infrastructure and Methodological Research for Cancer Epidemiology Cohorts (U01) Agency: NIH Institutions: NCI	03/29/17	05/07/20
Mechanisms of Alcohol-associated Cancers (R21) Agency: NIH Institutions: NIAAANCI	03/13/17	09/07/20
Mechanisms of Alcohol-associated Cancers (R01) Agency: NIH Institutions: NIAAANCI	03/13/17	09/07/20
Alliance of Glycobiologists for Cancer Research: Translational Tumor Glycomics Laboratories (U01) Agency: NIH Institutions: NCI	03/08/17	02/07/19
Alliance of Glycobiologists for Cancer Research: Biological Tumor Glycomics Laboratories (U01) Agency: NIH Institutions: NCI	03/08/17	02/07/19
Inter-organelle Communication in Cancer (R21) Agency: NIH Institutions: NCI	03/07/17	01/15/20
Inter-organelle Communication in Cancer (R01) Agency: NIH Institutions: NCI	03/07/17	01/15/20
Energy for Sustainability Agency: NSF	02/22/17	10/22/18
Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01) Agency: NIH Institutions: NCI	02/21/17	01/07/19
Mechanisms of Disparities in Chronic Liver Diseases and Cancer (R21) Agency: NIH Institutions: NIMHDNCINIAAA	02/02/17	04/04/19
Mechanisms of Disparities in Chronic Liver Diseases and Cancer (R01) Agency: NIH Institutions: NIMHDNCINIAAA	02/02/17	04/04/19
Development of Highly Innovative Tools and Technology for Analysis of Single Cells (STTR) (R41/R42) Agency: NIH Institutions: NIMHNCINHGRINIAMSNIDCRNIDDKNIEHSNCCIHNCATS	02/01/17	01/05/20
Development of Highly Innovative Tools and Technology for Analysis of Single Cells (SBIR) (R43/R44) Agency: NIH Institutions: NIMHNCINEINHGRINIAMSNIDCRNIDANIDDKNIEHSNIGMSNCCIHNCATS	02/01/17	01/05/20
Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30) Agency: NIH Institutions: NCI	12/21/16	01/07/20
Fertility Status as a Marker for Overall Health (R01) Agency: NIH Institutions: NICHDNIEHSODP	12/19/16	05/07/20
Tobacco Use and HIV in Low and Middle Income Countries (R01) Agency: NIH Institutions: NCINIDA	12/15/16	01/07/20
Tobacco Use and HIV in Low and Middle Income Countries (R21) Agency: NIH Institutions: NCINIDA	12/15/16	01/07/20
National Cancer Institute Youth Enjoy Science Research Education Program (R25) Agency: NIH Institutions: NCI	11/25/16	09/07/19
Addressing the Etiology of Health Disparities and Health Advantages Among Immigrant Populations (R01) Agency: NIH Institutions: NIMHDNCINIAAANIDCRNIDANIEHS	11/01/16	01/07/20
Addressing the Etiology of Health Disparities and Health Advantages Among Immigrant Populations (R21) Agency: NIH Institutions: NIMHDNCINIAAANIDCRNIDANIEHS	11/01/16	01/07/20
Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (R01) Agency: NIH Institutions: NCI	10/04/16	10/28/19
Emerging Global Leader Award (K43) Agency: NIH Institutions: FICNCINHGRINIDCRNIEHSNIMHNINDSORWH	10/04/16	12/14/18
Kidney Precision Medicine Project - Technology Development and Validation (R43/R44) Agency: NIH Institutions: NIDDK	09/28/16	01/05/20
Kidney Precision Medicine Project - Technology Development and Validation (R41/R42) Agency: NIH Institutions: NIDDK	09/28/16	01/05/20
Support of Competitive Research (SCORE) Pilot Project Award (SC2) Agency: NIH Institutions: NIGMSNCINHLBINIANIAIDNICHDNIDCDNIDCRNIDDKNIDANIEHSNIMHNINDS	09/21/16	09/07/19
Support of Competitive Research (SCORE) Research Advancement Award (SC1) Agency: NIH Institutions: NIGMSNCINHLBINIANIAIDNICHDNIDCDNIDCRNIDDKNIDANIMHNINDSNIEHS	09/21/16	09/07/19
"High" or "Medium" Priority AIDS Research on Non-AIDS-defining or AIDS-defining Cancers (R21) Agency: NIH Institutions: NCINIDCR	09/07/16	09/07/19
"High" or "Medium" Priority AIDS Research on Non-AIDS-defining or AIDS-defining Cancers (R01) Agency: NIH Institutions: NCINIDCR	09/07/16	09/07/19
Secondary Analyses of Alcohol and Chronic Disease (R03) Agency: NIH Institutions: NIAAANCI	08/10/16	09/07/19
Secondary Analyses of Alcohol and Chronic Disease (R01) Agency: NIH Institutions: NIAAANCI	08/10/16	09/07/19
Social Epigenomics Research Focused on Minority Health and Health Disparities (R21) Agency: NIH Institutions: NIMHDNCINIA	07/07/16	11/15/18
Social Epigenomics Research Focused on Minority Health and Health Disparities (R01) Agency: NIH Institutions: NIMHDNCINIA	07/07/16	11/15/18
New Informatics Tools and Methods to Enhance US Cancer Surveillance and Research (UG3/UH3) Agency: NIH Institutions: NCI	06/29/16	04/16/19
Biological Comparisons in Patient-Derived Models of Cancer (U01) Agency: NIH Institutions: NCI	06/24/16	03/06/19
Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R03) Agency: NIH Institutions: NCI	06/16/16	07/16/19
Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R21) Agency: NIH Institutions: NCI	06/08/16	04/11/19
Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R01) Agency: NIH Institutions: NCI	06/08/16	04/11/19
Factors Underlying Differences in Female and Male Presentation for Dental, Oral, and Craniofacial Diseases and Conditions (R01) Agency: NIH Institutions: NIDCRNIAORWH	05/27/16	09/07/19
Factors Underlying Differences in Female and Male Presentation for Dental, Oral, and Craniofacial Diseases and Conditions (R21) Agency: NIH Institutions: NIDCRNIAORWH	05/27/16	09/07/19
Program to Assess the Rigor and Reproducibility of Exosome-Derived Analytes for Cancer Detection (R01) Agency: NIH Institutions: NCI	05/23/16	06/13/19
Program to Assess the Rigor and Reproducibility of Exosome-Derived Analytes for Cancer Detection (R21) Agency: NIH Institutions: NCI	05/23/16	06/13/19
Serious Adverse Drug Reaction Research (R21) Agency: NIH Institutions: NHGRINCINIAIDNIAMSNINDS	05/19/16	09/07/19
Serious Adverse Drug Reaction Research (R01) Agency: NIH Institutions: NHGRINCINIAIDNIAMSNINDSNIMHD	05/19/16	09/07/19
Mechanisms of Cancer and Treatment-related Symptoms and Toxicities (R21) Agency: NIH Institutions: NCI	05/16/16	09/07/19
Cancer-related Behavioral Research through Integrating Existing Data (R21) Agency: NIH Institutions: NCI	05/11/16	06/14/19
Predicting Behavioral Responses to Population-Level Cancer Control Strategies (R21) Agency: NIH Institutions: NCI	05/11/16	04/11/19
Cancer-related Behavioral Research through Integrating Existing Data (R01) Agency: NIH Institutions: NCI	05/11/16	06/07/19
Gene Fusions in Pediatric Sarcomas (R21) Agency: NIH Institutions: NCI	05/10/16	05/07/19
Dissemination and Implementation Research in Health (R03) Agency: NIH Institutions: NCINHGRINIANIAAANICHDNIDCRNIDANIEHSNIMHNINDSFICODPOBSSR	05/10/16	05/07/19
Gene Fusions in Pediatric Sarcomas (R01) Agency: NIH Institutions: NCI	05/10/16	05/07/19
Neural Regulation of Cancer (R21) Agency: NIH Institutions: NCININDS	05/09/16	06/27/19
Neural Regulation of Cancer (R01) Agency: NIH Institutions: NCININDS	05/09/16	06/27/19
Metabolic Reprogramming to Improve Immunotherapy (R21) Agency: NIH Institutions: NCI	05/06/16	09/07/19
Metabolic Reprogramming to Improve Immunotherapy (R01) Agency: NIH Institutions: NCI	05/06/16	09/07/19
The Role of Mobile Genetic Elements in Cancer (R21) Agency: NIH Institutions: NCINIA	05/05/16	09/07/19
The Role of Mobile Genetic Elements in Cancer (R01) Agency: NIH Institutions: NCINIA	05/05/16	09/07/19
Tools for Cell Line Identification (R43/R44) Agency: NIH Institutions: NIGMSNCINIANIAIDNIBIBNIDCRNIDANINDSNCATSORIPORWHNHGRI	04/15/16	04/05/19
Exploratory Grants in Cancer Epidemiology and Genomics Research (R21) Agency: NIH Institutions: NCI	04/08/16	05/07/19
Pilot and Feasibility Studies Evaluating the Role of RNA Modifications (the 'epitranscriptome') in Cancer Biology (R21) Agency: NIH Institutions: NCI	04/08/16	07/16/19
Obesity Policy Evaluation Research (R01) Agency: NIH Institutions: NIDDKNCINIANICHDODPOBSSR	04/04/16	05/07/19
Cancer Research Education Grants Program to Promote Diversity - Courses for Skills Development (R25) Agency: NIH Institutions: NCI	03/17/16	01/07/19
Cancer Research Education Grants Program to Promote Diversity - Research Experiences (R25) Agency: NIH Institutions: NCI	03/17/16	01/07/19
Emerging Questions in Cancer Systems Biology (U01) Agency: NIH Institutions: NCI	03/11/16	11/23/18
Imaging and Biomarkers for Early Cancer Detection (U01) Agency: NIH Institutions: NCI	01/25/16	12/11/18
Education and Health: New Frontiers (R01) Agency: NIH Institutions: NCINIANICHDNIDAOBSSR	01/12/16	01/07/19
Small-Cell Lung Cancer (SCLC) Consortium: Therapeutic Development and Mechanisms of Resistance (U01) Agency: NIH Institutions: NCI	12/07/15	11/17/18
Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01) Agency: NIH Institutions: NCI	08/18/15	11/20/18
Advanced Development of Informatics Technologies for Cancer Research and Management (U24) Agency: NIH Institutions: NCI	08/18/15	11/20/18
Sustained Support for Informatics Resources for Cancer Research and Management (U24) Agency: NIH Institutions: NCI	08/18/15	11/20/18
Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21) Agency: NIH Institutions: NCI	08/18/15	11/20/18
Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01) Agency: NIH Institutions: NCI	07/14/15	08/15/18
Chemical Measurement and Imaging Agency: NSF	07/14/09	10/31/18

TOP